Track AOD‑9604 in Peptimes™
AOD-9604 is a synthetic peptide of 16 amino acids: a fragment of human growth hormone (amino acids 177 to 191) with an extra tyrosine at one end. (Source: FDA.)
Is AOD-9604 FDA-approved?
No. AOD-9604 isn't FDA-approved, and FDA says it isn't a component of any FDA-approved drug.
AOD-9604
Also: AOD9604, LAT-8881
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- SubcutaneousOral
- Updated
- 1 Nov 2026
US regulatory status
FDA status
Not FDA-Approved. FDA says AOD-9604 and its acetate are not a component of any FDA-approved drug.
Source: FDA, checked 1 Nov 2026
How to track it in Peptimes
Add AOD-9604 in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Routes: subcutaneous or oral. Choose the one that matches each dose.
- Logging: the amount you took, the route and how you feel.
- Injection sites: subcutaneous doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Oral doses skip this step.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell AOD-9604 or any other compound.
More sources
- FDA, Pharmacy Compounding Advisory Committee briefing document on AOD-9604 (meeting of 4 Dec 2024), checked 1 Nov 2026: its description as a 16-amino-acid fragment of human growth hormone with an added tyrosine, and that it is not a component of any FDA-approved drug.
- FDA, Global Substance Registration System, LAT-8881 (AOD-9604), checked 1 Nov 2026: its sequence of 16 amino acids and the names AOD-9604 and LAT-8881.